Biological analyses | Day1 = Inclusion (n = 45) n (%) | Day7 (n = 26) n (%) | Day14 (n = 16) n (%) | Day21 (n = 1) n (%) |
High sensitivity C-reactive protein (mg/L) |
|
|
|
|
<6 | 27 (60.00) | 19 (73.08) | 15 (93.75) | 1 (100.00) |
≤6 | 18 (40.00) | 7 (26.92) | 1 (6.25) |
|
Erythrocyte sedimentation rate (mm/h) |
|
|
|
|
≤10 | 12 (26.67) | 12 (46.15) | 13 (81.25) | 1 (100.00)
|
>10 | 33 (73.33) | 14 (53.85) | 3 (18.75) |
|
White blood cells (/mm3) |
|
|
|
|
<4000 | 3 (6.67) |
|
|
|
[4000 - 10,000] | 32 (71.11) | 22 (84.62) | 16 (100.00) | 1 (100.00) |
>10,000 | 10 (22.22) | 4 (15.38) |
|
|
Neutrophil count/(mm3) |
|
|
|
|
<1500 | 7 (15.55) | 3 (11.54) | 3 (18.75) |
|
[1500 - 7500] | 35 (77.78) | 22 (84.61) | 13 (81.25) | 1 (100.00) |
>7500 | 3 (6.67) | 1 (3.85) |
|
|
Lymphocyte count/mm3) |
|
|
|
|
<1000 |
|
|
|
|
[1000 - 4000] | 31 (68.89) | 17 (65.38) | 11 (68.75) | 1 (100.00) |
>4000 | 14 (31.11) | 9 (34.62) | 5 (31.25) |
|
Blood glucose level (mmol/L) |
|
|
|
|
<4.1 | 7 (15.56) |
|
|
|
[4.1 - 6.1] | 26 (57.78) |
|
|
|
>6.1 | 12 (26.67) |
|
|
|
Hemoglobin level (g/dL) |
|
|
|
|
<13 | 30 (66.67) | 16 (61.54) | 10 (62.50) | 1 (100.00) |
[13 - 17] | 15 (33.33) | 10 (38.46) | 6 (37.50) |
|
>17 |
|
|
|
|
Platelets (/mm3) |
|
|
|
|
<100,000 | 1 (2.22) |
|
|
|
[100,000 - 300,000] | 37 (82.22) | 15 (57.69) | 8 (50.00) | 1 (100.00) |
>300,000 | 7 (15.56) | 11 (42.31) | 8 (50.00) |
|
Alanine aminotransferase (U/L) |
|
|
|
|
Males |
|
|
|
|
≤40 | 19 (90.48) | 11 (91.67) | 8 (100.00) |
|
>40 | 2 (9.52) | 1 (8.33) |
|
|
Females |
|
|
|
|
≤31 | 22 (91.67) | 13 (92.86) | 7 (87.50) | 1 (100.00) |
>31 | 2 (8.33) | 1 (7.14) | 1 (12.50) |
|
Aspartate aminotransferase (U/L) |
|
|
|
|
Males |
|
|
|
|
≤38 | 20 (95.24) | 12 (100.00) | 8 (100.00) |
|
>38 | 1 (4.76) |
|
|
|
Females |
|
|
|
|
≤31 | 21 (87.50) | 12 (85.71) | 7 (87.50) | 1 (100.00) |
>31 | 3 (12.50) | 2 (14.29) | 1 (12.50) |
|
Creatinemia (µmol/l) |
|
|
|
|
Males |
|
|
|
|
<61.8 |
|
|
|
|
[61.8; 123.7] | 18 (85.71) | 12 (100.00) | 8 (100.00) | --- |
>123.7 | 3 (14.29) |
|
|
|
Females |
|
|
|
|
<53 | 1 (4.17) |
|
|
|
[53; 97.2] | 21 (87.50) | 12 (85.71) | 8 (100.00) | 1 (100.00)
|
>97.2 | 2 (8.33) | 2 (14.29) |
|
|